Noor Muhammad
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Noor Muhammad has a total of 26 co-authors. Here are the top co-authors by number of shared publications:
Waiza Ansar
Microbiology Lab, Department of Zoology, Government College University, Lahore, 54000, Pakistan
4 shared publicationsHubza Ruatt Khan
Department of Microbiology and Molecular Genetics, Women's University, Multan, Pakistan
3 shared publicationsTehmina Bashir
Lahore Medical Research Center Lahore, Lahore, Pakistan
3 shared publicationsHafiz Muhammad Ghuffran Qamar
GC University, Lahore, Pakistan
2 shared publicationsHusna Jurrat
Department of Zoology, Government College University, Lahore, Pakistan
2 shared publicationsIram Liaqat
Department of Zoology, Government College University, Lahore, Pakistan
2 shared publications
Latest Publications
- 23 May 2026
- Published by Springer Nature in Archives of Microbiology
- Vol. 208 (8)
Bacillus-derived antimicrobial peptides as alternatives to antibiotics in poultry: mechanisms, applications, and future prospects— a review
Bacterial enteric pathogens, antimicrobial resistance, and mycotoxin-associated intestinal injury remain important challenges in poultry-associated systems. In this context, Bacillus-derived antimicrobial peptides (AMPs) have attracted attention as potential alternatives to conventional antibiotics due to their structural diversity and multifunctional properties. These peptides include ribosomally synthesized bacteriocins and non-ribosomally synthesized lipopeptides, such as surfactin, iturin, and fengycin. Their amphipathic structures enable interaction with microbial membranes, leading to permeabilization and disruption of cellular homeostasis. In addition to direct antimicrobial activity, these AMPs may interfere with biofilm-associated processes, modulate host immune responses, and help protect against toxin-induced epithelial injury. This review summarizes current knowledge on the diversity, structural characteristics, biosynthesis, mechanisms of action, and microbiological relevance of Bacillus AMPs in poultry-associated environments. Emphasis is placed on membrane targeting, biofilm regulation, immunomodulation, and mycotoxin-related gut protection, as well as limitations associated with antimicrobial resistance. Available evidence indicates that these peptides have diverse mechanisms of action; however, their activity is influenced by peptide class, formulation, microbial ecology, and host physiological factors. In addition, the potential for adaptive or genetically encoded resistance should be considered. Key translational challenges include peptide instability, variability in in vivo efficacy, strain-specific differences, safety considerations, and the lack of standardized comparative models. Future progress will depend on improved delivery systems, microbiome-resolved in vivo studies, and the integration of genomic mining, synthetic biology, and computational peptide design. These approaches may support the development of AMPs with improved stability, specificity, and functional performance in poultry-associated microbial systems.
- 23 May 2026
- Published by Springer Nature in Archives of Microbiology
- Vol. 208 (8)
Bacillus-derived antimicrobial peptides as alternatives to antibiotics in poultry: mechanisms, applications, and future prospects— a review
Bacterial enteric pathogens, antimicrobial resistance, and mycotoxin-associated intestinal injury remain important challenges in poultry-associated systems. In this context, Bacillus-derived antimicrobial peptides (AMPs) have attracted attention as potential alternatives to conventional antibiotics due to their structural diversity and multifunctional properties. These peptides include ribosomally synthesized bacteriocins and non-ribosomally synthesized lipopeptides, such as surfactin, iturin, and fengycin. Their amphipathic structures enable interaction with microbial membranes, leading to permeabilization and disruption of cellular homeostasis. In addition to direct antimicrobial activity, these AMPs may interfere with biofilm-associated processes, modulate host immune responses, and help protect against toxin-induced epithelial injury. This review summarizes current knowledge on the diversity, structural characteristics, biosynthesis, mechanisms of action, and microbiological relevance of Bacillus AMPs in poultry-associated environments. Emphasis is placed on membrane targeting, biofilm regulation, immunomodulation, and mycotoxin-related gut protection, as well as limitations associated with antimicrobial resistance. Available evidence indicates that these peptides have diverse mechanisms of action; however, their activity is influenced by peptide class, formulation, microbial ecology, and host physiological factors. In addition, the potential for adaptive or genetically encoded resistance should be considered. Key translational challenges include peptide instability, variability in in vivo efficacy, strain-specific differences, safety considerations, and the lack of standardized comparative models. Future progress will depend on improved delivery systems, microbiome-resolved in vivo studies, and the integration of genomic mining, synthetic biology, and computational peptide design. These approaches may support the development of AMPs with improved stability, specificity, and functional performance in poultry-associated microbial systems.
- 6 January 2026
- Published by Springer Nature in Archives of Microbiology
- Vol. 208 (2) , 87
Probiotic-based mycotoxin detoxification in poultry feed: mechanisms, efficacy, challenges, and future directions for sustainable production
Mycotoxin contamination remains a significant challenge to poultry health and productivity globally. Conventional detoxification methods, such as chemical adsorption and thermal degradation, are often limited by high costs, nutrient losses, and incomplete toxin removal. In contrast, probiotics offer a promising biological alternative for mycotoxin detoxification. This review critically evaluates the role of probiotics, such as Lactobacillus, Bacillus, and Saccharomyces, in mitigating mycotoxin toxicity through mechanisms of adsorption to cell wall polysaccharides and enzymatic degradation. Probiotic strains Lactobacillus casei and Saccharomyces cerevisiae achieve adsorption efficiencies exceeding 90% for aflatoxins B (AFB₁), while Bacillus strains have demonstrated up to 65% reduction in deoxynivalenol levels in vitro. The detoxification efficacy of probiotics is highly strain- and dose-dependent, with reductions in AFB₁ residues ranging from 30 to 60% in poultry tissue during in vivo trials. While adsorption is well established, the in vivo enzymatic degradation mechanisms remain underexplored, with some strains showing up to a 40% reduction in toxin residues through enzymatic biotransformation. Additionally, emerging strategies using microbial consortia and genetically modified probiotics show promising results, with consortia reducing toxin loads by 40–65% in field trials. However, large-scale validation and consistent performance in commercial poultry production remain limited. This review identifies critical research gaps, including strain selection, biofilm regulation, and the need for standardized field-level efficacy trials. Probiotic-based detoxification is positioned as a biologically sustainable complement to, rather than a complete replacement for, conventional chemical methods, offering potential for safer feed and improved poultry health within a broader food safety framework.
- 6 January 2026
- Published by Springer Nature in Archives of Microbiology
- Vol. 208 (2) , 87
Probiotic-based mycotoxin detoxification in poultry feed: mechanisms, efficacy, challenges, and future directions for sustainable production
Mycotoxin contamination remains a significant challenge to poultry health and productivity globally. Conventional detoxification methods, such as chemical adsorption and thermal degradation, are often limited by high costs, nutrient losses, and incomplete toxin removal. In contrast, probiotics offer a promising biological alternative for mycotoxin detoxification. This review critically evaluates the role of probiotics, such as Lactobacillus, Bacillus, and Saccharomyces, in mitigating mycotoxin toxicity through mechanisms of adsorption to cell wall polysaccharides and enzymatic degradation. Probiotic strains Lactobacillus casei and Saccharomyces cerevisiae achieve adsorption efficiencies exceeding 90% for aflatoxins B (AFB₁), while Bacillus strains have demonstrated up to 65% reduction in deoxynivalenol levels in vitro. The detoxification efficacy of probiotics is highly strain- and dose-dependent, with reductions in AFB₁ residues ranging from 30 to 60% in poultry tissue during in vivo trials. While adsorption is well established, the in vivo enzymatic degradation mechanisms remain underexplored, with some strains showing up to a 40% reduction in toxin residues through enzymatic biotransformation. Additionally, emerging strategies using microbial consortia and genetically modified probiotics show promising results, with consortia reducing toxin loads by 40–65% in field trials. However, large-scale validation and consistent performance in commercial poultry production remain limited. This review identifies critical research gaps, including strain selection, biofilm regulation, and the need for standardized field-level efficacy trials. Probiotic-based detoxification is positioned as a biologically sustainable complement to, rather than a complete replacement for, conventional chemical methods, offering potential for safer feed and improved poultry health within a broader food safety framework.
- Open Access
- 31 July 2025
- Published by CrossLinks International Publishers in Pakistan BioMedical Journal
- p. 49-55
Microbial Contamination of Healthcare Personnel and Devices: A Critical Route for Pathogen Transmission
Since healthcare workers are often exposed to pathogenic organisms, they can unintentionally transfer disease to patients, causing healthcare-associated infections (HAIs). Objectives: To isolate healthcare staff and their respective equipment to determine the level of contamination and the pattern of antibiotic resistance. Methods: A total of 153 samples were taken out of doctors (n=52), nurses (n=44), lab technicians (n=33), and ward boys (n=24) in Nishtar Hospital, Multan, in this cross-sectional study that was based on laboratory procedures. Hands, stethoscopes, and mobile phones were taken, cultured on selective medium, and identified to the level of genus. Antibiotic susceptibility was evaluated using the Kirby–Bauer disc diffusion method against piperacillin (100 µg), ciprofloxacin (5 µg), levofloxacin (5 µg), gentamicin (10 µg), and imipenem (10 µg). Data were analyzed using ANOVA at a 95% confidence level. Results: Out of 153 samples, 93 (60.13%) yielded positive bacterial cultures. The highest number of positive cultures was recorded among lab technicians (63.64%), followed by ward boys (62.50%), doctors (57.69%), and nursing staff (56.82%) (p<0.05). The most frequently isolated bacteria were Bacillus sp. (22.58%), Enterococcus sp. (19.35%), and Escherichia sp. (17.20%). Mobile phones (45.16%) showed the highest contamination, followed by hands (37.63%) and stethoscopes (35.48%). All Enterococcus isolates were 100% resistant to Piperacillin, while all Staphylococcus and Klebsiella isolates showed complete resistance to multiple antibiotics. Conclusions: Healthcare personnel and their commonly used devices act as reservoirs for multidrug-resistant bacteria. Strict adherence to infection control protocols and specialized training for healthcare staff are essential to minimize cross-contamination and prevent HAIs.
- 31 July 2025
- Published by CrossLinks International Publishers in Pakistan BioMedical Journal
- p. 49-55
Open AccessMicrobial Contamination of Healthcare Personnel and Devices: A Critical Route for Pathogen Transmission
Since healthcare workers are often exposed to pathogenic organisms, they can unintentionally transfer disease to patients, causing healthcare-associated infections (HAIs). Objectives: To isolate healthcare staff and their respective equipment to determine the level of contamination and the pattern of antibiotic resistance. Methods: A total of 153 samples were taken out of doctors (n=52), nurses (n=44), lab technicians (n=33), and ward boys (n=24) in Nishtar Hospital, Multan, in this cross-sectional study that was based on laboratory procedures. Hands, stethoscopes, and mobile phones were taken, cultured on selective medium, and identified to the level of genus. Antibiotic susceptibility was evaluated using the Kirby–Bauer disc diffusion method against piperacillin (100 µg), ciprofloxacin (5 µg), levofloxacin (5 µg), gentamicin (10 µg), and imipenem (10 µg). Data were analyzed using ANOVA at a 95% confidence level. Results: Out of 153 samples, 93 (60.13%) yielded positive bacterial cultures. The highest number of positive cultures was recorded among lab technicians (63.64%), followed by ward boys (62.50%), doctors (57.69%), and nursing staff (56.82%) (p<0.05). The most frequently isolated bacteria were Bacillus sp. (22.58%), Enterococcus sp. (19.35%), and Escherichia sp. (17.20%). Mobile phones (45.16%) showed the highest contamination, followed by hands (37.63%) and stethoscopes (35.48%). All Enterococcus isolates were 100% resistant to Piperacillin, while all Staphylococcus and Klebsiella isolates showed complete resistance to multiple antibiotics. Conclusions: Healthcare personnel and their commonly used devices act as reservoirs for multidrug-resistant bacteria. Strict adherence to infection control protocols and specialized training for healthcare staff are essential to minimize cross-contamination and prevent HAIs.
- 16 July 2025
- Published by Springer Nature in Molecular Biology Reports
- Vol. 52 (1) , 1-16
Indigenous aseel chicken-derived probiotics as biofactories of antifungal metabolites to control mycotoxin contamination in poultry feed
Background Fungal and mycotoxin contamination threaten poultry health, feed safety, and global food security. Mycotoxins result in reduced poultry growth, nutrient absorption, and a compromised immune system, causing severe financial losses. The rise of antibiotic resistance due to excessive antibiotic use in poultry also necessitates alternative strategies. Methods and results Total 28 strains were isolated from the gut of indigenous Aseel and broiler chickens. Strains SB1, SB2, and SD2 completely inhibited Aspergillus flavus, Aspergillus ochraceus, and Fusarium proliferatum and were assessed via spore germination and mycotoxin reduction assays. The strains significantly inhibited fungal spore germination (up to 91.7 ± 0.3%;P ≤ 0.001) and reduced aflatoxin, ochratoxin, and fumonisin production by 91.6 ± 1.2%, 93.6 ± 0.6%, and 93.0 ± 0.5%, respectively. FTIR analysis of bacterial metabolites revealed shifts in peaks at 1467–3240 cm− 1, indicating the presence of various functional groups. LC-MS/MS metabolomics, supported by multivariate analysis, revealed that metabolites were enriched with antifungal and mycotoxin-reducing compounds, including phenylacetic acid. Metabolites showed zones of inhibition up to 38.0 ± 1.1 mm against A. flavus, up to 36.0 ± 0.5 mm against A. ochraceus, and up to 34.0 ± 0.5 mm ZOI against F. proliferatum (P ≤ 0.0001). They also showed the lowest minimum inhibitory concentrations and fungicidal concentrations between 3 and 5 µLmL− 1 (P ≤ 0.001). 16 S rRNA sequencing identified SB1 as Bacillus subtilis (PV569530), SB2 as Bacillus clausii (PV569531), and SD2 as Bacillus sp. (PV569532). Conclusion Thus, this study highlights the microflora of indigenous Aseel chickens as a potential source of antifungal and mycotoxin-reducing compounds, offering a sustainable approach to control fungal and mycotoxin contamination in poultry feed. Clinical trial number As this study did not involve higher animals, no clinical trial number was required. Graphical Abstract
- 16 July 2025
- Published by Springer Nature in Molecular Biology Reports
- Vol. 52 (1) , 1-16
Indigenous aseel chicken-derived probiotics as biofactories of antifungal metabolites to control mycotoxin contamination in poultry feed
Background Fungal and mycotoxin contamination threaten poultry health, feed safety, and global food security. Mycotoxins result in reduced poultry growth, nutrient absorption, and a compromised immune system, causing severe financial losses. The rise of antibiotic resistance due to excessive antibiotic use in poultry also necessitates alternative strategies. Methods and results Total 28 strains were isolated from the gut of indigenous Aseel and broiler chickens. Strains SB1, SB2, and SD2 completely inhibited Aspergillus flavus, Aspergillus ochraceus, and Fusarium proliferatum and were assessed via spore germination and mycotoxin reduction assays. The strains significantly inhibited fungal spore germination (up to 91.7 ± 0.3%;P ≤ 0.001) and reduced aflatoxin, ochratoxin, and fumonisin production by 91.6 ± 1.2%, 93.6 ± 0.6%, and 93.0 ± 0.5%, respectively. FTIR analysis of bacterial metabolites revealed shifts in peaks at 1467–3240 cm− 1, indicating the presence of various functional groups. LC-MS/MS metabolomics, supported by multivariate analysis, revealed that metabolites were enriched with antifungal and mycotoxin-reducing compounds, including phenylacetic acid. Metabolites showed zones of inhibition up to 38.0 ± 1.1 mm against A. flavus, up to 36.0 ± 0.5 mm against A. ochraceus, and up to 34.0 ± 0.5 mm ZOI against F. proliferatum (P ≤ 0.0001). They also showed the lowest minimum inhibitory concentrations and fungicidal concentrations between 3 and 5 µLmL− 1 (P ≤ 0.001). 16 S rRNA sequencing identified SB1 as Bacillus subtilis (PV569530), SB2 as Bacillus clausii (PV569531), and SD2 as Bacillus sp. (PV569532). Conclusion Thus, this study highlights the microflora of indigenous Aseel chickens as a potential source of antifungal and mycotoxin-reducing compounds, offering a sustainable approach to control fungal and mycotoxin contamination in poultry feed. Clinical trial number As this study did not involve higher animals, no clinical trial number was required. Graphical Abstract
- Open Access
- 31 March 2025
- Published by CrossLinks International Publishers in Futuristic Biotechnology
- p. 10-19
The Role of Lifestyle in Modulating the Gut Microbiome
The human gut, a dynamic and diverse ecosystem of trillions of microorganisms, plays an essential role in the host's health and disease. This review explores the influence of lifestyle choices like diet, stress, physical activity, and environmental factors on gut microbiome and their broader societal implications. Studies have reported that plant-based and Mediterranean diets enhance microbial diversity. At the same time, a sedentary lifestyle, chronic stress, processed foods, and alcohol consumption badly impact on the gut microbial composition and lead to many diseases like dysbiosis, obesity, and cardiovascular diseases. Geographic and ethnic factors also influence the gut microbiome. The consumption of fermented food and a diet high in fiber has a positive impact on the gut microbiome. The gut microbiome also has many societal implications, and the targeted intervention can help to reduce economic losses and public health costs and improve the overall health of everyone. This comprehensive review focuses on the links between lifestyle, gut microbiome, and societal well-being and suggests integrative strategies to promote sustainable health practices.
- 31 March 2025
- Published by CrossLinks International Publishers in Futuristic Biotechnology
- p. 10-19
Open AccessThe Role of Lifestyle in Modulating the Gut Microbiome
The human gut, a dynamic and diverse ecosystem of trillions of microorganisms, plays an essential role in the host's health and disease. This review explores the influence of lifestyle choices like diet, stress, physical activity, and environmental factors on gut microbiome and their broader societal implications. Studies have reported that plant-based and Mediterranean diets enhance microbial diversity. At the same time, a sedentary lifestyle, chronic stress, processed foods, and alcohol consumption badly impact on the gut microbial composition and lead to many diseases like dysbiosis, obesity, and cardiovascular diseases. Geographic and ethnic factors also influence the gut microbiome. The consumption of fermented food and a diet high in fiber has a positive impact on the gut microbiome. The gut microbiome also has many societal implications, and the targeted intervention can help to reduce economic losses and public health costs and improve the overall health of everyone. This comprehensive review focuses on the links between lifestyle, gut microbiome, and societal well-being and suggests integrative strategies to promote sustainable health practices.
- Open Access
- 21 March 2025
- Published by University of Management and Technology in BioScientific Review
- Vol. 7 (2) , 32-53
Development of Microbial Biofilms and Their Role in device, non-device and organ system level Infections
Background. Microorganisms, while providing many health benefits to human beings and other living organisms, are also responsible for significant infections. They cause infections in both planktonic and biofilm modes. Biofilms, defined as architectural communities of microorganisms encased in an extracellular polymeric substance (EPS), are strongly associated with infections. According to the National Institute of Health Sciences (NIH), biofilms account for 65% of microbial infections and 80% of chronic infections. Methods. This review examines the current literature on microbial biofilms, focusing on their formation stages, pathogenicity, resistance mechanisms, and associated infections. Data from various studies is analyzed to summarize biofilm development and its role in chronic infections. Results. Biofilm development involves four stages: attachment, microcolony formation, maturation, and dispersion. Quorum sensing (QS) mechanisms play a critical role in biofilm development and microbial communication. Biofilms enhance microbial pathogenicity and resistance to both the immune system and commercial antibiotics. They contribute to device-associated infections, such as those in catheters, and also to non-device infections in living tissues, as well as organ-level infections that impair systemic functions. Conclusion. A comprehensive understanding of microbial biofilms is essential for developing strategies to manage and control biofilm-associated infections. This review highlights the need for further research on the mechanisms of biofilm formation and resistance to improve infection prevention and treatment. Keywords: biofilm development, biofilm infections, chronic infections, device infections, microbial biofilms, non-device infections
- 21 March 2025
- Published by University of Management and Technology in BioScientific Review
- Vol. 7 (2) , 32-53
Open AccessDevelopment of Microbial Biofilms and Their Role in device, non-device and organ system level Infections
Background. Microorganisms, while providing many health benefits to human beings and other living organisms, are also responsible for significant infections. They cause infections in both planktonic and biofilm modes. Biofilms, defined as architectural communities of microorganisms encased in an extracellular polymeric substance (EPS), are strongly associated with infections. According to the National Institute of Health Sciences (NIH), biofilms account for 65% of microbial infections and 80% of chronic infections. Methods. This review examines the current literature on microbial biofilms, focusing on their formation stages, pathogenicity, resistance mechanisms, and associated infections. Data from various studies is analyzed to summarize biofilm development and its role in chronic infections. Results. Biofilm development involves four stages: attachment, microcolony formation, maturation, and dispersion. Quorum sensing (QS) mechanisms play a critical role in biofilm development and microbial communication. Biofilms enhance microbial pathogenicity and resistance to both the immune system and commercial antibiotics. They contribute to device-associated infections, such as those in catheters, and also to non-device infections in living tissues, as well as organ-level infections that impair systemic functions. Conclusion. A comprehensive understanding of microbial biofilms is essential for developing strategies to manage and control biofilm-associated infections. This review highlights the need for further research on the mechanisms of biofilm formation and resistance to improve infection prevention and treatment. Keywords: biofilm development, biofilm infections, chronic infections, device infections, microbial biofilms, non-device infections
- Open Access
- 30 September 2024
- Published by CrossLinks International Publishers in Futuristic Biotechnology
- p. 62-67
Antibacterial Activity of Transition Metal Complexes of 2-(2-Hydroxybenzylidene) Hydrazinecarbothioamide
Thiosemicarbazone derivatives in the form of metal complexes have been sought after superior antibacterial effects than free ligands. Objectives: To prepare new Cu (II), Co (II), Mn (II), and Cd (II) complexes of 2 (2-hydroxybenzylidene) hydrazinecarbothioamide and assess their antimicrobial characteristics against some pathogenic microorganisms. Methods: This was a laboratory-based experimental study, which synthesized and characterized complexes by means of standard analytical and spectroscopic methods. Against Bacillus licheniformis, Escherichia coli, and Pseudomonas aeruginosa, the agar well diffusion method was evaluated at 12.5, 25, and 50 mg/mL. The values of MIC and MBC were calculated by the broth dilution method. The results were provided in the form of mean and SD, and statistical analysis was carried out by one-way ANOVA (p<0.05). Results: All the metal complexes showed concentration-dependent antibacterial activity. B. licheniformis was the most sensitive strain, in comparison to E. coli and P. aeruginosa. The Cu (II) and Mn (II) complexes had the strongest inhibitory effect, with the value of MIC and MBC, respectively, between 10 and 20mg/mL against B. licheniformis. Co (II) and Cd (II) complexes were moderately active depending on the strain of bacteria. Conclusions: Coordination of 2-(2-hydroxybenzylidene) hydrazinecarbothioamide with transition metals enhances antibacterial activity in a metal- and dose-dependent manner. Cu (II) and Mn (II) complexes displayed the most promising antibacterial properties, supporting the potential of metal-thiosemicarbazone complexes as candidates for developing new antimicrobial agents. Further mechanistic and toxicity studies are warranted.
- 30 September 2024
- Published by CrossLinks International Publishers in Futuristic Biotechnology
- p. 62-67
Open AccessAntibacterial Activity of Transition Metal Complexes of 2-(2-Hydroxybenzylidene) Hydrazinecarbothioamide
Thiosemicarbazone derivatives in the form of metal complexes have been sought after superior antibacterial effects than free ligands. Objectives: To prepare new Cu (II), Co (II), Mn (II), and Cd (II) complexes of 2 (2-hydroxybenzylidene) hydrazinecarbothioamide and assess their antimicrobial characteristics against some pathogenic microorganisms. Methods: This was a laboratory-based experimental study, which synthesized and characterized complexes by means of standard analytical and spectroscopic methods. Against Bacillus licheniformis, Escherichia coli, and Pseudomonas aeruginosa, the agar well diffusion method was evaluated at 12.5, 25, and 50 mg/mL. The values of MIC and MBC were calculated by the broth dilution method. The results were provided in the form of mean and SD, and statistical analysis was carried out by one-way ANOVA (p<0.05). Results: All the metal complexes showed concentration-dependent antibacterial activity. B. licheniformis was the most sensitive strain, in comparison to E. coli and P. aeruginosa. The Cu (II) and Mn (II) complexes had the strongest inhibitory effect, with the value of MIC and MBC, respectively, between 10 and 20mg/mL against B. licheniformis. Co (II) and Cd (II) complexes were moderately active depending on the strain of bacteria. Conclusions: Coordination of 2-(2-hydroxybenzylidene) hydrazinecarbothioamide with transition metals enhances antibacterial activity in a metal- and dose-dependent manner. Cu (II) and Mn (II) complexes displayed the most promising antibacterial properties, supporting the potential of metal-thiosemicarbazone complexes as candidates for developing new antimicrobial agents. Further mechanistic and toxicity studies are warranted.